7/1/2022  9:10:40 AM Chg. 0.0000 Volume Bid9:56:40 PM Ask9:56:40 PM Market Capitalization Dividend Y. P/E Ratio
26.3900EUR 0.00% 0
Turnover: 0.0000
-Bid Size: - -Ask Size: - 41.77 bill.EUR - -

Business description

Located in Osaka, Japan, Takeda (TYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.
 

Management board & Supervisory board

CEO
Christophe Weber
Management board
Costa Saroukos, Dr. Andrew S. Plump, Dr. Masato Iwasaki, Gerard Greco, Giles Platford, Julie Kim, Koki Sato, Lauren Duprey, Marcello Agosti, Milano Furuta, Mwana Lugogo, Rajeev Venkayya, Ramona Sequeira, Ricardo Marek, Takako Ohyabu, Teresa Bitetti, Thomas Wozniewski, Yoshihiro Nakagawa
Supervisory board
Christophe Weber, Costa Saroukos, Dr. Andrew Plump, Dr. Masato Iwasaki, Emiko Higashi, Ian Clark, Jean-Luc Butel, Koji Hatsukawa, Masahiro Sakane, Masami Iijima, Michel Orsinger, Olivier Bohuon, Shiro Kuniya, Steven Gillis, Toshiyuki Shiga, Yoshiaki Fujimori
 

Company data

Name: Takeda Pharmaceutical Company Ltd.
Address: 1-1, Nihonbashi-Honcho 2-Chome,Chuo-ku, Tokyo 103-8668, Japan
Phone: +81-3-3278-2306
Fax: +81-3-3278-2268
E-mail: -
Internet: www.takeda.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 3/31
Free Float: 78.45%
IPO date: -

Investor relations

Name: -
IR phone: +81-3-3278-2037
IR Fax: +81-3-3278-2741
IR e-mail: -

Main Shareholders

Freefloat
 
78.45%
The Master Trust Bank of Japan, Ltd.
 
7.98%
JP Morgan Chase Bank 385632
 
5.39%
Japan Trustee Services Bank, Ltd.
 
5.15%
JP Morgan Chase Bank 385632
 
3.03%